Lipella Pharmaceuticals Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx |
|---|---|---|---|
| FY2021 | $-989.3K | $-989.3K | — |
| FY2022 | $-1.8M | $-1.8M | — |
| FY2023 | $-3.2M | $-3.2M | $14.4K |
| FY2024 | $-4.0M | $-4.0M | — |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx |
|---|---|---|---|
| FY2021 | $-989.3K | $-989.3K | — |
| FY2022 | $-1.8M | $-1.8M | — |
| FY2023 | $-3.2M | $-3.2M | $14.4K |
| FY2024 | $-4.0M | $-4.0M | — |